Close



Jan 26, 2023 07:00AM
Aug 17, 2022 08:01AM
Aug 17, 2022 08:00AM
Feb 18, 2021 07:00AM
Jan 6, 2021 07:00AM
Nov 20, 2020 08:02AM
Nov 20, 2020 08:00AM RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease
Oct 14, 2020 11:00AM
Oct 14, 2020 11:00AM
Jul 31, 2020 07:12AM
Jul 31, 2020 07:00AM
Jan 2, 2020 09:09AM
Jan 2, 2020 09:00AM
Nov 4, 2019 06:06AM RedHill Biopharma (RDHL) Reports FDA Approval of Talicia for Treatment of H. pylori in Adults
Nov 4, 2019 06:05AM
Jul 3, 2019 07:29AM
Jul 3, 2019 07:00AM
May 7, 2019 06:25AM
May 7, 2019 06:05AM
May 7, 2019 06:05AM
Mar 4, 2019 08:10AM RedHill Biopharma (RDHL) Announces New European and Japanese Patents for Talicia
Mar 4, 2019 08:00AM
Mar 4, 2019 08:00AM
Jan 17, 2019 08:02AM
Jan 17, 2019 08:00AM
Jan 17, 2019 08:00AM
Dec 3, 2018 07:02AM
Dec 3, 2018 07:01AM RedHill Biopharma Announces Positive Top-Line Results from Confirmatory Phase 3 Study with TALICIA® for H. pylori Infection
Dec 3, 2018 07:01AM
Oct 29, 2018 07:00AM
Oct 29, 2018 07:00AM
Oct 24, 2018 08:01AM
Oct 24, 2018 08:00AM
Oct 24, 2018 08:00AM
Sep 4, 2018 07:03AM RedHill Biopharma (RDHL) Reports Completion of Enrollment for Confirmatory Phase III Study with TALICIA for H. pylori Infection
Sep 4, 2018 07:00AM
Sep 4, 2018 07:00AM
Jul 24, 2018 08:24AM
Jul 24, 2018 08:22AM
Jul 24, 2018 08:22AM
May 4, 2018 07:08AM
May 4, 2018 07:00AM RedHill Biopharma Announces Enrollment of 300th Patient in Confirmatory Phase III Study with TALICIA® for H. pylori Infection
May 4, 2018 07:00AM
Jun 15, 2017 08:03AM
Jun 15, 2017 08:00AM
Jan 10, 2017 08:21AM
Jan 10, 2017 08:00AM
Nov 10, 2016 08:05AM
Nov 10, 2016 08:00AM RedHill Biopharma Reports Positive FDA Type B Meeting on RHB-105 for H. pylori Infection Ahead of Confirmatory Phase III Study
Jul 21, 2016 09:05AM

2,758 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All